
111, Inc.
YINASDAQHealthcareMedical - Distribution
終値時点
$3.53
−$0.03 · -0.84%
時間外
$3.81
+$0.28 · +7.93%
8月24日 19:30 ET
YIの企業概要
日中の時刻はETです。市場データは遅延する場合があります。
GoAIリサーチ・スナップショット
利用可能な最新のモデル情報を簡潔にまとめています。
GoAI スコア
Sell
Trim exposure — unfavorable risk-reward
バリュエーション
35
Expensive
モメンタム
26
Weakening
センチメント
57
Mixed
リスク耐性
32
High Risk
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
AI によって生成されたコンテキストは情報提供のみを目的としており、投資アドバイスではありません。
企業プロフィール
会社ウェブサイトBased in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.
- 業界
- Medical - Distribution
- セクター
- Healthcare
- 本社
- CN
- 最高経営責任者(CEO)
- Junling Liu
- 上場以来
- 2018年9月12日
- 従業員
- 1,063
市場での位置
日中レンジ
現在 $3.53
52週レンジ
現在 $3.53
- 始値
- $3.68
- 前日終値
- $3.56
- 出来高
- 1803
- 0.1× 平均
- 平均出来高
- 1.81万
- 1日平均出来高
- 時価総額
- 3083.83万 USD
- ベータ
- 0.67
- 市場参照 1
- 50日平均
- $3.9406
- 平均以下(-10.42%)
- 200日平均
- $5.1383
- 平均以下(-31.30%)
財務
財務スナップショット
直近12か月バリュエーションと利回り
- 企業価値
- -1.88億 CNY
- PER (TTM)
- -2.43×
- P/B(TTM)
- -1.95×
- P/S(TTM)
- 0.02×
- EV/EBITDA
- -103.85×
- 収益利回り
- -10.81%
- フリーキャッシュフロー利回り
- 73.63%
- 配当利回り
- 0.00%
収益性と効率性
- 粗利益率
- 5.74%
- 営業利益率
- -0.24%
- 純利益率
- -0.66%
- 自己資本利益率
- 2.40%
- 資産利益率
- -0.77%
- 投下資本利益率
- -2.31%
財務の健全性
- 負債資本比率
- -0.38×
- 流動比率
- 1.09×
YI ニュース
YIの同業他社
GoAI で研究を続ける
GoAIでYIを調査research.disclaimer







